Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer. N Engl J Med. 2010;363(20):1938–48.

Article  CAS  PubMed  Google Scholar 

Popovic LS, Matovina-Brko G, Popovic M, Punie K, Cvetanovic A, Lambertini M. Targeting triple-negative breast cancer: A clinical perspective. Oncol Res. 2023;31(3):221–38.

Article  PubMed  PubMed Central  Google Scholar 

de Faria BJ, Marta GN. Triple-negative breast cancer and radiation therapy. Reports of practical oncology and radiotherapy. J Greatpoland Cancer Center Poznan Polish Soc Rad Oncol. 2022;27(3):545–51.

Google Scholar 

Burguin A, Diorio C, Durocher F. Breast Cancer treatments: updates and new challenges. J Personal Med. 2021;11(8):808.

Article  Google Scholar 

Wu Y, Song Y, Wang R, Wang T. Molecular mechanisms of tumor resistance to radiotherapy. Mol Cancer. 2023;22(1):96.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aranza-Martínez A, Sánchez-Pérez J, Brito-Elias L, et al. Non-coding RNAs associated with radioresistance in triple-negative breast cancer. Front Oncol. 2021;11: 752270.

Article  PubMed  PubMed Central  Google Scholar 

McCann E, O’Sullivan J, Marcone S. Targeting cancer-cell mitochondria and metabolism to improve radiotherapy response. Trans Oncol. 2021;14(1): 100905.

Article  CAS  Google Scholar 

Averbeck D, Rodriguez-Lafrasse C. Role of mitochondria in radiation responses: epigenetic, metabolic, and signaling impacts. Int J Mol Sci. 2021;22(20):11047.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Picca A, Guerra F, Calvani R, et al. The contribution of mitochondrial DNA alterations to aging, cancer, and neurodegeneration. Exp Gerontol. 2023;178: 112203.

Article  CAS  PubMed  Google Scholar 

Bakare AB, Lesnefsky EJ, Iyer S. Leigh Syndrome: A Tale of Two Genomes. Front Physiol. 2021;12: 693734.

Article  PubMed  PubMed Central  Google Scholar 

Kotrys AV, Szczesny RJ. Mitochondrial gene expression and beyond-novel aspects of cellular physiology. Cells. 2019;9(1):17.

Article  PubMed  PubMed Central  Google Scholar 

Shadel GS. Expression and maintenance of mitochondrial DNA: new insights into human disease pathology. Am J Pathol. 2008;172(6):1445–56.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aso T, Lane WS, Conaway JW, Conaway RC. Elongin (SIII): a multisubunit regulator of elongation by RNA polymerase II. Science (New York, NY). 1995;269(5229):1439–43.

Article  ADS  CAS  Google Scholar 

Hwang J, Saffert RT, Kalejta RF. Elongin B-mediated epigenetic alteration of viral chromatin correlates with efficient human cytomegalovirus gene expression and replication. mBio. 2011;2(2):e00023

Schieven SM, Traets JJH, Vliet AV, et al. The elongin BC complex negatively regulates AXL and marks a differentiated phenotype in melanoma. Mol Cancer Res. 2023;21(5):428–43.

Article  CAS  PubMed  Google Scholar 

Schoenfeld AR, Davidowitz EJ, Burk RD. Elongin BC complex prevents degradation of von Hippel-Lindau tumor suppressor gene products. Proc Natl Acad Sci USA. 2000;97(15):8507–12.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Deng Z, Zhou J, Han X, Li X. TCEB2 confers resistance to VEGF-targeted therapy in ovarian cancer. Oncol Rep. 2016;35(1):359–65.

Article  CAS  PubMed  Google Scholar 

Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F. Genome engineering using the CRISPR-Cas9 system. Nat Protoc. 2013;8(11):2281–308.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bonekamp NA, Peter B, Hillen HS, et al. Small-molecule inhibitors of human mitochondrial DNA transcription. Nature. 2020;588(7839):712–6.

Article  ADS  CAS  PubMed  Google Scholar 

Fischer S, Trinh VT, Simon C, et al. Peptide-mediated inhibition of the transcriptional regulator Elongin BC induces apoptosis in cancer cells. Cell Chem Biol. 2023;30(7):766-79.e11.

Article  CAS  PubMed  Google Scholar